DABRA Excimer Laser Atherectomy to be Presented in Key Events at Charing Cross International Symposium
Ra Medical Systems Inc., headquartered in Carlsbad, California, has scheduled its key DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) Excimer Laser Atherectomy events at the upcoming Charing Cross International Symposium in London April 16–18. Ra Medical is in Booth No. 509.
These events include case and podium presentations and hands-on workshops with Charles Bailey, MD, interventional cardiologist at Heart Endovascular and Rhythm of Texas in San Antonio, and Max Amor, MD, interventional cardiologist at Clinique Louis Pasteur in Nancy, France.
“DABRA has given me a means of atherectomy that is safe, versatile and efficacious. I am hopeful that this new technology will decrease scar tissue formation and the need for recurrent revascularization,” Dr. Bailey said. “With the high rates of peripheral artery disease in my community of San Antonio, Texas, DABRA has allowed me to save limbs and deliver improved quality of life for my patients.”
According to Ra Medical Systems CEO Dean Irwin, DABRA is a novel, minimally invasive excimer laser atherectomy system that non-thermally, photochemically ablates channels in vascular blockages. Unlike many mechanical, acoustic, or thermal treatments for peripheral artery disease (PAD) that may damage the arterial wall, DABRA treats blockages with minimal vascular trauma.
“Every year, there are greater than 200,000 lower limb amputations in the U.S. directly related to vascular disease,” Irwin said. “The revolutionary DABRA Excimer Laser Atherectomy System provides a treatment option to quickly, safely, and efficaciously restore blood flow, save patients’ limbs, and improve their lives.”
The schedule of DABRA events is:
- Tuesday, April 16: “CX” taught by Dr. Amor from 10-11:30 a.m. in the Peripheral Village.
- Tuesday, April 16: “Peripheral Hands-on Workshop” taught by Dr. Bailey from 12:30-1:30 p.m. and from 3-4 p.m., also in the Peripheral Village.
- Wednesday, April 17: “Edited Case: Excimer Laser Atherectomy in Retrograde, No Stump” taught by Dr. Amor from 10-10:30 a.m. in the Lower Main Auditorium.
- Wednesday, April 17: “Peripheral Hands-on Workshop” taught by Dr. Bailey from 12:30-1:30 p.m. and from 3:30-4 p.m., in the Peripheral Village.
- Thursday, April 18: “New Wireless Laser: Mechanism and Initial Experience” taught by Dr. Bailey from 10:19-10:27 a.m. in the Piliar Hall Learning Centre.
The Charing Cross Symposium is one of the largest vascular and endovascular symposiums in the world. The Symposium facilitates scientific exchanges and peer-to-peer interactions between a world-class faculty and 4,000 participants from 86 countries.
DABRA launched in 2017 for the endovascular treatment of blockages resulting from lower extremity vascular disease and is CE marked for the indication of the endovascular treatment of infrainguinal arteries via atherectomy, and for crossing total occlusions. Pharos launched in 2004 for the treatment of dermatological disorders including psoriasis, vitiligo, and atopic dermatitis.
DABRA and Pharos are based on Ra Medical’s core excimer laser technology platform that produces 308 nanometer light, a UVB wavelength that studies have demonstrated increases T-cell apoptosis, or cell death, which may produce a beneficial, targeted immunosuppressive effect. VTN
READ MORE: www.ramed.com